SEER Cancer Statistics Review 1975-2017, Section 28: Childhood Cancer by Site, Table 28.8 (5-year relative survival by year of diagnosis) (2020)

Government Record · National Cancer Institute, Surveillance, Epidemiology, and End Results (SEER) Program · April 15, 2020

National Cancer Institute et al., 2020-04-15: SEER table of 5-year relative survival by year of diagnosis for childhood cancers. For ages 0-19, acute lymphocytic leukaemia rose from 53.8% (1975-1977) to 90.4% (2010-2016), and Hodgkin lymphoma from 86.2% to 98.2%.

Acute lymphocytic 53.8 61.9 66.9 69.9 75.0 79.8 81.5 84.4 84.8 88.0 90.0 90.4c

p.11 (Table 28.8, ages 0-19 block)

National Cancer Institute et al., 2020-04-15: SEER table of 5-year relative survival by year of diagnosis for childhood cancers. For ages 0-19, acute lymphocytic leukaemia rose from 53.8% (1975-1977) to 90.4% (2010-2016), and Hodgkin lymphoma from 86.2% to 98.2%. US government work; the CSR's citation page states the material is in the public domain. Excerpt is a table row, not prose: the twelve columns are successive diagnosis periods from 1975-1977 to 2010-2016, and the trailing 'c' is the CSR's footnote marker. Caveat for C2: SEER begins in 1975, by which time combination chemotherapy for childhood ALL was already standard, so 53.8% is a post-chemotherapy baseline, not a pre-treatment one; no pre-1960s figure exists in SEER. Study type: other.